<DOC>
	<DOCNO>NCT00848848</DOCNO>
	<brief_summary>The study evaluate safety , tolerability immunogenicity different dos type Influenza Vaccine healthy elderly subject .</brief_summary>
	<brief_title>Safety , Tolerability , Immunogenicity Different Combinations Trivalent Influenza Vaccine Varying Influenza Antigen Dose , Adjuvant Dose , Route Administration Healthy Elderly Individuals Ages 65 Years Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects 65 year old generally good health determine medical history , physical assessment clinical judgment investigator . Subjects received influenza vaccine within past 6 month receive adjuvanted vaccine past two year . Subjects hypersensitivity vaccine component . Subjects recently immunosuppressive therapy .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Flu</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Intradermal</keyword>
	<keyword>Adjuvant</keyword>
</DOC>